Merit Medical Systems (NASDAQ:MMSI) Insider Brian Lloyd Sells 16,722 Shares of Stock

Merit Medical Systems, Inc. (NASDAQ:MMSI – Get Free Report) insider Brian Lloyd sold 16,722 shares of the company’s stock in a transaction that occurred on Monday, November 16th. The stock was sold at an average price of $86.33, for a total value of $1,443,610.26. Following the completion of the sale, the insider owned 60,132 shares of the company’s stock, valued at $5,191,195.56. This trade represents a 21.76% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Merit Medical Systems Stock Performance

Shares of NASDAQ MMSI opened at $84.49 on Wednesday. The stock has a fifty day moving average price of $87.90 and a two-hundred day moving average price of $77.45. The company has a debt-to-equity ratio of 0.42, a quick ratio of 3.05 and a current ratio of 4.52. The firm has a market cap of $5.06 billion, a P/E ratio of 31.76, a PEG ratio of 2.10 and a beta of 0.56. Merit Medical Systems, Inc. has a 1 year low of $59.74 and a 1 year high of $94.85.

Merit Medical Systems (NASDAQ:MMSI – Get Free Report) last issued its quarterly earnings results on Thursday, October 29th. The medical instruments supplier reported $1.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $0.08. Merit Medical Systems had a return on equity of 14.12% and a net margin of 9.94%. The company had revenue of $416.24 million for the quarter, compared to analysts’ expectations of $410.56 million. During the same period last year, the firm earned $0.92 EPS. The firm’s revenue for the quarter was up 8.4% on a year-over-year basis. Research analysts forecast that Merit Medical Systems, Inc. will post 3.86 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Allworth Financial LP lifted its holdings in shares of Merit Medical Systems by 16.3% in the third quarter. Allworth Financial LP now owns 2,232 shares of the medical instruments supplier’s stock valued at $192,000 after purchasing an additional 312 shares in the last quarter. Pure Financial Advisors LLC boosted its position in shares of Merit Medical Systems by 7.3% in the third quarter. Pure Financial Advisors LLC now owns 4,358 shares of the medical instruments supplier’s stock worth $376,000 after buying an additional 296 shares during the period. Aquatic Capital Management LLC acquired a new stake in shares of Merit Medical Systems in the third quarter worth $180,000. CSM Advisors LLC acquired a new stake in shares of Merit Medical Systems in the third quarter worth $1,716,000. Finally, Jump Financial LLC grew its holdings in shares of Merit Medical Systems by 25.9% during the third quarter. Jump Financial LLC now owns 52,591 shares of the medical instruments supplier’s stock valued at $4,535,000 after buying an additional 10,825 shares in the last quarter. Institutional investors own 99.66% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on MMSI. Barrington Research set a $114.00 target price on Merit Medical Systems in a report on Friday, July 31st. Robert W. Baird set a $98.00 price target on shares of Merit Medical Systems in a report on Friday, July 31st. Freedom Capital assumed coverage on shares of Merit Medical Systems in a report on Tuesday, October 27th. They issued a “hold” rating for the company. JPMorgan Chase & Co. raised their price objective on shares of Merit Medical Systems from $95.00 to $110.00 and gave the company an “overweight” rating in a research report on Friday, October 30th. Finally, Wells Fargo & Company lifted their price objective on shares of Merit Medical Systems from $83.00 to $92.00 and gave the stock an “equal weight” rating in a research note on Friday, October 30th. Eight equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $105.91.

Get Our Latest Stock Report on MMSI

Merit Medical Systems Company Profile

(Get Free Report)

Merit Medical Systems develops, manufactures and markets medical devices used in diagnostic and interventional procedures. Its products support clinicians in areas including cardiology, radiology, oncology and endoscopy. The company’s portfolio includes devices and accessories for vascular access, diagnostic and therapeutic procedures, drainage, biopsy and embolization. Merit serves hospitals, clinics and other healthcare providers through direct sales and distribution channels. Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves customers in the United States and internationally.

See Also

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.